Related Experiment Video

Updated: May 11, 2026

Implantation of Total Artificial Heart in Congenital Heart Disease
07:27

Implantation of Total Artificial Heart in Congenital Heart Disease

Published on: July 18, 2014

Neurodevelopmental outcome in children with congenital heart disease

Miriam Martinez-Biarge1, Victoria C Jowett, Frances M Cowan

  • 1Department of Paediatrics, Hammersmith Hospital, Imperial College, London, UK.

Seminars in Fetal & Neonatal Medicine
|May 28, 2013
PubMed

Insights

Children with congenital heart disease (CHD) face risks for neurodevelopmental issues. Early recognition and long-term follow-up are crucial for optimizing outcomes in these children.

Area of Science:

  • Pediatric Cardiology
  • Neurodevelopmental Pediatrics
  • Congenital Heart Disease Research

Background:

  • Children with congenital heart disease (CHD) exhibit increased vulnerability to neurodevelopmental difficulties.
  • Improved survival rates in CHD necessitate a focus on neurodevelopmental outcomes.
  • Early brain development differences and perinatal injury risks are observed in CHD populations.

Purpose of the Study:

  • To highlight the multifactorial risks for neurodevelopmental challenges in children with CHD.
  • To emphasize the importance of recognizing and managing neurodevelopmental risks in CHD care.
  • To advocate for comprehensive neurodevelopmental assessment and intervention strategies.

Main Methods:

  • Review of neuroimaging studies demonstrating early brain alterations in CHD.
  • Analysis of factors contributing to increased risk of brain injury.
  • Synthesis of evidence for predicting neurodevelopmental prognosis in individual children.

Main Results:

  • Children with CHD show early brain development differences.
  • Perinatal complications and comorbidities exacerbate the risk of brain injury.
  • A combination of factors is required to estimate neurodevelopmental prognosis.

Conclusions:

  • Long-term neurodevelopmental follow-up is essential for children with CHD.
  • Early identification and intervention are critical for addressing neurodevelopmental difficulties.
  • Optimizing neurodevelopmental outcomes should be a key component of CHD management.

Keywords:
Congenital heart defectInfantMagnetic resonance imagingNeurodevelopmentNeurologyNewbornOutcome

More Related Videos

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System07:34

Fetal Mouse Cardiovascular Imaging Using a High-frequency Ultrasound (30/45MHZ) System

Published on: May 5, 2018

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest04:55

Pediatric Animal Model of Extracorporeal Cardiopulmonary Resuscitation After Prolonged Circulatory Arrest

Published on: May 26, 2023

Related Concept Videos

Cardiomyopathy III: Hypertrophic Cardiomyopathy01:29

Cardiomyopathy III: Hypertrophic Cardiomyopathy

Hypertrophic cardiomyopathy, or HCM, is an autosomal dominant genetic disorder characterized by asymmetric left ventricular hypertrophy without ventricular dilation. It is more common in men and is typically diagnosed in young, athletic adults.EtiologyHCM is primarily genetic and is caused by mutations in genes encoding sarcomeric proteins. Researchers have identified over 1400 mutations across at least 11 different genes. Among these, the most frequently occurring mutations are found in the...
Cardiomyopathy II: Dilated Cardiomyopathy01:30

Cardiomyopathy II: Dilated Cardiomyopathy

Dilated cardiomyopathy, or DCM, is a progressive myocardial disorder characterized by ventricular chamber dilation and contractile dysfunction.EtiologyVarious factors can cause DCM, including hypertension and heavy alcohol intake, which contribute to the weakening and enlargement of the heart muscle. Viral infections, such as Coxsackievirus B, adenoviruses, and influenza, can lead to DCM by causing inflammation and damage to heart tissue. Certain chemotherapeutic agents, including daunorubicin,...
Heart Failure II: Pathophysiology01:29

Heart Failure II: Pathophysiology

Systolic Heart Failure and Compensatory MechanismsSystolic heart failure (also termed HFrEF, Heart Failure with Reduced Ejection Fraction) is the most prevalent type of heart filure. It results in a decreased volume of blood being pumped from the ventricle. The aortic arch and carotid sinuses have baroreceptors that detect reduced blood pressure, triggering the sympathetic nervous system (SNS) to release epinephrine and norepinephrine. Initially, this response aims to boost heart rate and...
Heart Failure IV: Classification and Diagnostic Evaluation01:30

Heart Failure IV: Classification and Diagnostic Evaluation

Heart failure can be classified in various ways, with the most common classifications based on physical activity limitations, disease progression, severity, and treatment strategies.The Functional Classification of Heart Failure divides patients into four categories based on physical activity limitation due to symptom burden.Class I: Patients in this class have cardiac disease but no physical activity limitations. Ordinary activities like walking, climbing stairs, or routine tasks do not cause...
Pathophysiology of Heart Failure01:17

Pathophysiology of Heart Failure

Heart failure (HF) is a progressive syndrome involving ventricles that leads to inadequate cardiac output. It can be classified based on location and output or ejection fraction. Ejection fraction (EF) is an essential measurement in the diagnosis and surveillance of HF. Reduced EF corresponds to systolic heart failure (HFrEF). However, HF with preserved ejection fraction (HFpEF) is becoming increasingly prevalent. Also known as diastolic HF, this form of HF is related to aging. The...
Heart Failure I: Introduction01:27

Heart Failure I: Introduction

Heart failure refers to a clinical syndrome caused by structural or functional cardiac disorders that prevent the heart from pumping an adequate amount of blood to meet the body's metabolic needs. This condition often arises from myocardial infarction or ischemia, leading to decreased cardiac output, reduced tissue perfusion, impaired gas exchange, fluid volume imbalance, and decreased functional ability.Heart failure can result from disruptions in the mechanisms that regulate cardiac output...